| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 55.66M | 63.76M | 52.59M | 37.46M | 27.97M | 18.67M |
| Gross Profit | 33.41M | 32.66M | 33.89M | 33.06M | 24.04M | 13.16M |
| EBITDA | 1.23M | 3.52M | 7.30M | 8.93M | -4.21M | -928.00K |
| Net Income | 616.00K | 1.93M | 4.51M | 5.64M | -4.05M | -642.00K |
Balance Sheet | ||||||
| Total Assets | 1.23B | 1.30B | 1.38B | 1.18B | 1.09B | 483.38M |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 146.32M | 422.14M | 344.85M | 387.92M | 106.81M |
| Total Debt | 133.00M | 262.14M | 396.79M | 205.81M | 151.91M | 113.81M |
| Total Liabilities | 941.64M | 1.02B | 1.09B | 904.64M | 952.40M | 434.49M |
| Stockholders Equity | 285.55M | 285.16M | 281.90M | 279.48M | 141.00M | 48.88M |
Cash Flow | ||||||
| Free Cash Flow | -1.13M | 1.25M | 7.39M | 6.00M | -514.00K | -13.97M |
| Operating Cash Flow | -1.07M | 1.39M | 7.59M | 6.32M | 624.00K | -13.55M |
| Investing Cash Flow | 53.84M | 28.22M | -100.04M | -323.96M | 25.02M | 50.71M |
| Financing Cash Flow | -126.78M | -73.45M | 181.54M | 102.22M | 109.82M | 43.39M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | $74.36M | 13.91 | 5.50% | 2.13% | 1.28% | -35.83% | |
68 Neutral | $77.01M | 9.73 | 10.86% | 2.35% | 6.17% | -6.13% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
62 Neutral | $73.62M | 10.03 | 10.99% | 7.19% | 6.30% | -3.81% | |
51 Neutral | $83.07M | -10.98 | -4.68% | 3.08% | 8.02% | 21.26% | |
48 Neutral | $57.93M | -22.22 | 0.22% | ― | 2.54% | -174.74% | |
45 Neutral | $72.44M | -51.32 | -1.41% | ― | -0.80% | -129.22% |
On October 15, 2025, Broadway Financial Corporation announced that its Audit Committee determined the company’s goodwill is impaired, leading to a non-cash $25.9 million goodwill impairment charge for the quarter ended September 30, 2025. This charge is not expected to result in future cash expenditures, indicating limited immediate financial impact on the company’s operations.
The most recent analyst rating on (BYFC) stock is a Hold with a $7.50 price target. To see the full list of analyst forecasts on Broadway Financial stock, see the BYFC Stock Forecast page.
On August 21, 2025, Broadway Financial Corporation received a notification from Nasdaq regarding non-compliance with Listing Rule 5250(c)(1) due to the late filing of its Form 10-Q for the quarter ended June 30, 2025. The delay was attributed to the need for additional time to evaluate participation agreements for compliance with accounting standards. Nasdaq has given the company 60 days to submit a compliance plan, with the potential for an extension until February 16, 2026, if the plan is accepted. The company aims to file the Form 10-Q promptly to meet the deadline.
The most recent analyst rating on (BYFC) stock is a Hold with a $8.50 price target. To see the full list of analyst forecasts on Broadway Financial stock, see the BYFC Stock Forecast page.
Broadway Financial Corporation has announced a delay in filing its Form 10-Q (Quarter Report) for the financial period ending June 30, 2025. The primary reason for the delay is the need for additional time to evaluate participation agreements for compliance with Accounting Standards Codification Topic 860, which impacts the consolidated financial statements. The company anticipates filing the report within five calendar days following the prescribed due date. Preliminary financial information indicates a net loss for the quarter, contrasting with a net income in the corresponding period last year, due to changes in accounting treatment. The company is actively working on compliance efforts, and the notification was signed by Zack Ibrahim, Executive Vice President and Chief Financial Officer.